Notably, GFPT1 has been implicated in interacting with PI3K/AKT/mTOR signaling, to impact the metabolic reprogramming associated with cancer as well as diabetic and cardiac diseases (Fig. 4) [85–87]. This evidence concerns the gene GFPT1 and cancer.